Red blood cell products and the storage of red blood cells in containers free of phthalate plasticizer

US9993389B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9993389-B2
Application numberUS-201214122847-A
CountryUS
Kind codeB2
Filing dateSep 19, 2012
Priority dateSep 19, 2011
Publication dateJun 12, 2018
Grant dateJun 12, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Red blood cell products and compositions are disclosed. The product includes a container made from PVC or a non-PVC material that is substantially free of a phthalate plasticizer but otherwise includes one or more non-phthalate plasticizers or extractable agents. The product includes a RBC concentrate which has been combined with an additive solution for storing the RBCs.

First claim

Opening claim text (preview).

The invention claimed is: 1. A container for storing red blood cell compositions comprising: one or more container walls defining an interior chamber, said container wall(s) comprising a polymeric material that includes polyvinyl chloride and that is (a) at least substantially free of phthalate and (b) comprises up to approximately 45%, by weight, of two extractable non-phthalate ester plasticizers that are effective in suppressing hemolysis in red blood cells, wherein one of said plasticizers is a citrate ester and the other of said ester plasticizers is 1, 2-cyclohexane dicarboxylic acid diisononyl ester. 2. The container of claim 1 wherein said citrate ester is n-butyryl-tri-n-hexyl-citrate. 3. The container of claim 1 wherein said citrate ester is acetyltri-n-butyl citrate. 4. The container of claim 1 further comprising at least a third agent. 5. The container of claim 4 wherein said third agent is effective in suppressing hemolysis in red blood cells. 6. The container of claim 1 wherein said citrate and 1, 2-cyclohexane dicarboxylic acid diisononyl esters together comprise between 20%-45%, by weight, of said polymeric material. 7. The container of claim 1 wherein one of said citrate and 1, 2-cyclohexane dicarboxylic acid diisononyl esters together comprises between approximately 5%-60%, by weight, of the combined weight of said citrate and 1, 2-cyclohexane dicarboxylic acid diisononyl ester and, optionally, additional agents. 8. The container of claim 1 wherein said polyvinyl chloride comprises at least approximately 55%, by weight, of said polymeric material. 9. The container of claim 1 wherein said polymeric material comprises approximately 60%-70% polyvinyl chloride, approximately 15%-30% 1, 2-cyclohexane dicarboxylic acid diisononyl ester and approximately 5%-15% citrate ester. 10. The container of claim 9 further comprising approximately 4%-10% epoxidized oil. 11. The container of claim 10 further comprising approximately 0.5%-3.0% of additional co-stabilizers and lubricants. 12. The container of claim 9 wherein said citrate ester is n-butyryl-tri-n-hexyl-citrate.

Assignees

Inventors

Classifications

  • Human Necessities · mapped topic

  • Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title

  • A61J1/10Primary

    Bag-type containers · CPC title

  • comprising vinyl halide (co)polymers, e.g. PVC, PVDC, PVF, PVDF · CPC title

  • of synthetic resin · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9993389B2 cover?
Red blood cell products and compositions are disclosed. The product includes a container made from PVC or a non-PVC material that is substantially free of a phthalate plasticizer but otherwise includes one or more non-phthalate plasticizers or extractable agents. The product includes a RBC concentrate which has been combined with an additive solution for storing the RBCs.
Who is the assignee on this patent?
Fenwal Inc
What technology area does this patent fall under?
Primary CPC classification A61J1/10. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).